Polyhemoglobin–Tyrosinase, an Oxygen Carrier with Murine B16F10 Melanoma Suppression Properties: A Preliminary Report

References

• Barthelmes H. U., Niederberger E., Roth T., Schulte K., Tang W. C., Boege F., Fiebig H. H., Eisenbrand G., Marko D. Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumor cells. Br. J. Cancer 2001; 85: 1585–1591, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Beahers O. H., Henson D. E., Hutter R. V. P., Kennedy B. J. Malignant melanoma of the skin (excluding eyelid). American Joint Committee on Cancer Manual for Staging of Cancer. 4th ed. JB Lippincott, Philadelphia 1992; 143–148
   Google Scholar
• Melanoma: Biologically Targeted Therapeutics, E. C. Borden. Humana Press, Totowa, NJ 2002; pp. 39–72
   Google Scholar
• Burd R., Lavorgna S. N., Daskalakis C., Wachsberger P. R., Wahl M. L., Biaglow J. E., Stevens C. W., Leeper D. B. Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-lodo-benzylguanidine. Radiat. Res. 2003; 159: 328–335, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Karger Publisher, Basel, New York 1997; Vol. I, (available for free access on www.artcell.mcgill.ca)
   Google Scholar
• Chang T. M. S. Red blood cell substitutes. Best Pract. Res. Clin. Haematol. 2000; 13: 651–668, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chang T. M. S. Future generations of red blood cell substitutes. J. Intern. Med. 2003; 253: 527–535, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cooper J. S. The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma. Hematol. Oncol. Clin. North Am. 1998; 12: 849–862, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Duckworth H. W., Coleman J. E. Physiochemical and kinetic properties of mushroom tyrosinase. J. Biol. Chem. 1970; 245: 1613–1625, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fu Y. M., Yu Z. X., Pelayo B. A., Ferrans V. J., Meadows G. G. Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency. Cancer Res. 1999; 59: 758–765, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Gili A., Thomas P. D., Ota M., Jimbow K. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Melanoma Res. 2000; 10: 9–15, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gould S. A. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J. Am. Coll. Surgeons 2002; 195: 445–452, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jimbow K. Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway. J. Med. Sci. 1998; 73: 105–110
   Google Scholar
• Kayaga J., Souberbielle B. E., Sheikh N., Morrow W. J., Scott-Taylor T., Vile R., Chong H., Dalgleish A. G. Anti-tumor activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumor cell vaccine. Gene Ther. 1999; 6: 1475–1481, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Letellier S., Garnier J. P., Spy J., Stoitchkov K., Le Bricon T., Baccard M., Revol M., Kerneis Y., Bousquet B. Development of metastases in malignant melanoma is associated with an increase in the plasma. Melanoma Res. 1999; 9: 389–394, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lorincz A. B., Kuttner R. E., Brandt M. B. Tumor response to phenylalanine-tyrosine limited diets. J. Am. Diet. Assoc. 1969; 54: 198–205, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Meadows G. G., Pierson H. F., Abdallah R. M., Desai P. R. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. Cancer Res 1982; 42: 3056–3063, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pelayo B. A., Fu Y. M., Meadows G. G. Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plaminogen activator inhibitors. Clin. Exp. Metastasis 1999; 17: 841–848, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Pelayo B. A., Fu Y. M., Meadows G. G. Decreased tissue plaminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine. Int. J. Oncol. 2001; 18: 877–883, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Potterf B. S., Hearing V. J. Tyrosine transport into melanosomes is increased following stimulation of melanocyte differentiation. Biochem. Biophys. Res. Commun. 1998; 248: 795–800, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Rodriguez-ayerbe C., Smith-zubiaga I. Effect of serum withdrawal on the proliferation of B16F10 melanoma cells. Cell Biol. Int. 2000; 24: 279–283, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sprung J., Kindscher J. D., Wahr J. A., Levy J. H., Monk T. G., Moritz M. W., O’Hara P. J. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesth. Analg. 2002; 94: 799–808, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Squires J. E. Artificial blood. Science 2002; 295: 1002–1005, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yu B., Chang T. M. S. Effects of combined oral administration and intravenous injection on maintaining decreased systemic tyrosine levels in rats. Artif. Cells Blood Substit. Biotechnol. 2004a; 32: 129–147, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yu B., Chang T. M. S. In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase. Biotechnol. Bioeng. 2004b, (in press)[CSA]
   Google Scholar
• Yu B., Chang T. M. S. In vitro and in vivo effects of polyhemoglobin-tyrosinase on murine B16F10 melanoma. Melanoma Res. 2004c, (in press)
   PubMedGoogle Scholar